These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29156504)

  • 1. Clinical risk reclassification at 10 years.
    Cook NR; Demler OV; Paynter NP
    Stat Med; 2017 Dec; 36(28):4498-4502. PubMed ID: 29156504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.
    Demler OV; Pencina MJ; Cook NR; D'Agostino RB
    Stat Med; 2017 Sep; 36(21):3334-3360. PubMed ID: 28627112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First things first: risk model performance metrics should reflect the clinical application.
    Kerr KF; Janes H
    Stat Med; 2017 Dec; 36(28):4503-4508. PubMed ID: 29156498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simpson's paradox in the integrated discrimination improvement.
    Chipman J; Braun D
    Stat Med; 2017 Dec; 36(28):4468-4481. PubMed ID: 29160558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Net reclassification index at event rate: properties and relationships.
    Pencina MJ; Steyerberg EW; D'Agostino RB
    Stat Med; 2017 Dec; 36(28):4455-4467. PubMed ID: 27426413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What to expect from net reclassification improvement with three categories.
    Pencina KM; Pencina MJ; D'Agostino RB
    Stat Med; 2014 Dec; 33(28):4975-87. PubMed ID: 25176621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of reclassification statistics in comparing risk prediction models.
    Cook NR; Paynter NP
    Biom J; 2011 Mar; 53(2):237-58. PubMed ID: 21294152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of polygenic risk models using multiple performance measures: a critical assessment of discordant results.
    Martens FK; Tonk ECM; Janssens ACJW
    Genet Med; 2019 Feb; 21(2):391-397. PubMed ID: 29895851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian reclassification statistics for assessing improvements in diagnostic accuracy.
    Huang Z; Li J; Cheng CY; Cheung C; Wong TY
    Stat Med; 2016 Jul; 35(15):2574-92. PubMed ID: 26875442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining risk markers improves cardiovascular risk prediction in women.
    Holewijn S; den Heijer M; Kiemeney LA; Stalenhoef AF; de Graaf J
    Clin Sci (Lond); 2014 Jan; 126(2):139-46. PubMed ID: 23879211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring improvement in fracture risk prediction for a new risk factor: a simulation.
    Lix LM; Leslie WD; Majumdar SR
    BMC Res Notes; 2018 Jan; 11(1):62. PubMed ID: 29357907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population.
    McGeechan K; Macaskill P; Irwig L; Bossuyt PM
    BMC Med Res Methodol; 2014 Jul; 14():86. PubMed ID: 24989719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lin JS; Evans CV; Johnson E; Redmond N; Coppola EL; Smith N
    JAMA; 2018 Jul; 320(3):281-297. PubMed ID: 29998301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the effect of multiple genetic risk score models on colorectal cancer risk prediction.
    Xin J; Chu H; Ben S; Ge Y; Shao W; Zhao Y; Wei Y; Ma G; Li S; Gu D; Zhang Z; Du M; Wang M
    Gene; 2018 Oct; 673():174-180. PubMed ID: 29908285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
    Hilden J; Gerds TA
    Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary information improves cardiovascular disease risk prediction models.
    Baik I; Cho NH; Kim SH; Shin C
    Eur J Clin Nutr; 2013 Jan; 67(1):25-30. PubMed ID: 23149979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination slope and integrated discrimination improvement - properties, relationships and impact of calibration.
    Pencina MJ; Fine JP; D'Agostino RB
    Stat Med; 2017 Dec; 36(28):4482-4490. PubMed ID: 27699818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.
    Enserro DM; Demler OV; Pencina MJ; D'Agostino RB
    Stat Med; 2019 Sep; 38(20):3817-3831. PubMed ID: 31211443
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.